{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:29:16Z","timestamp":1764102556806},"reference-count":15,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2011,1,9]],"date-time":"2011-01-09T00:00:00Z","timestamp":1294531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2011,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Non\u2010cultured cellular grafting as a surgical procedure is indicated to treat stable vitiligo, refractory to medical treatment, and is gaining wider acceptance among dermatologists.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> The aim of this study was to assess the efficacy of non\u2010cultured melanocyte\u2010keratinocyte transplantation (MKT) for the treatment of generalized vitiligo in Iranian patients.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> In this clinical trial, a total of 14 vitiligo patches in eight patients were treated; eight patches with non\u2010cultured MKT and six patches dermabraded alone without application of keratinocyte\u2010melanocyte suspension. Repigmentation was compared at about 4\u2003months post\u2010transplantation.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Of the eight lesions treated with non\u2010cultured MKT, four lesions showed 96\u2013100% repigmentation, one lesion 65\u201395% and three lesions 0\u201325%. Of the patients who showed excellent results, only one showed a post\u2010inflammatory hyperpigmentation in recipient and control areas. Of the six control lesions, five showed failed repigmentation and one showed post\u2010inflammatory hyperpigmentation.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Non\u2010cultured MKT is an effective method to treat stable vitiligo. Studies on larger series of vitiligo patients are required to confirm its efficacy.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2010.03946.x","type":"journal-article","created":{"date-parts":[[2011,1,10]],"date-time":"2011-01-10T01:41:31Z","timestamp":1294623691000},"page":"1182-1186","source":"Crossref","is-referenced-by-count":20,"title":["Non\u2010cultured melanocyte\u2010keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population"],"prefix":"10.1111","volume":"25","author":[{"given":"P.","family":"Toossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Shahidi\u2010Dadras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mahmoudi Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.","family":"Fesharaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,9]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.09.048"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1968.tb12282.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000199325"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(69)91421-4"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08718.x"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70024-A"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02177.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2001.01045.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08216.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.12968\/jowc.2002.11.4.26385"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2007.00426.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2005.02226.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.10.1211"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/BCR.0b013e3181a28c4d"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.45106"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2010.03946.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2010.03946.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T20:43:37Z","timestamp":1697316217000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2010.03946.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,9]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["10.1111\/j.1468-3083.2010.03946.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03946.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,9]]}}}